Congress Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,400
Closed -$1.2M 393
2023
Q3
$1.2M Sell
10,400
-1,245
-11% -$134K 0.01% 302
2023
Q2
$1.2M Sell
11,645
-47,778
-80% -$5.04M 0.01% 302
2023
Q1
$6.49M Sell
59,423
-1,253,712
-95% -$139M 0.06% 194
2022
Q4
$149M Sell
1,313,135
-251,611
-16% -$20.9M 1.5% 5
2022
Q3
$96.8M Sell
1,564,746
-19,699
-1% -$1.38M 1.04% 36
2022
Q2
$126M Sell
1,584,445
-19,416
-1% -$1.84M 1.21% 16
2022
Q1
$169M Sell
1,603,861
-11,698
-0.7% -$1.14M 1.44% 10
2021
Q4
$174M Sell
1,615,559
-46,547
-3% -$5.08M 1.33% 16
2021
Q3
$182M Sell
1,662,106
-51,729
-3% -$5.37M 1.42% 10
2021
Q2
$160M Sell
1,713,835
-44,177
-3% -$4.07M 1.34% 14
2021
Q1
$162M Sell
1,758,012
-95,445
-5% -$8.05M 1.46% 9
2020
Q4
$136M Sell
1,853,457
-26,273
-1% -$1.95M 1.28% 22
2020
Q3
$146M Sell
1,879,730
-75,654
-4% -$5.21M 1.58% 8
2020
Q2
$109M Buy
1,955,384
+1,717,803
+723% +$73.5M 1.29% 19
2020
Q1
$7.04M Sell
237,581
-17,043
-7% -$577K 0.11% 113
2019
Q4
$9.22M Sell
254,624
-10,934
-4% -$335K 0.11% 107
2019
Q3
$7.23M Sell
265,558
-13,288
-5% -$344K 0.09% 119
2019
Q2
$6.71M Sell
278,846
-5,551
-2% -$141K 0.09% 140
2019
Q1
$7.52M Buy
+284,397
New +$6.74M 0.1% 125

Other funds holding HZNP